KMT2A Rearrangements or NPM1 Mutations Acute Leukemia: Clinical Trials

1 trial for KMT2A Rearrangements or NPM1 Mutations Acute Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow KMT2A Rearrangements or NPM1 Mutations Acute Leukemia: new trials by email Literature Review of KMT2A Rearrangements or NPM1 Mutations Acute Leukemia trials Research Report on KMT2A Rearrangements or NPM1 Mutations Acute Leukemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BY002 IIT Study in R/R Acute Leukemia
BY002 - Acute Leukemia, KMT2A Rearrangements or NPM1 Mutations Acute Leukemia
Phase 1RecruitingThe First Affiliated Hospital of Soochow University182026-03-152026-03-18

Narrower conditions

Recurrence (1)

Broader conditions

Disease Attributes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Sponsors

The First Affiliated Hospital of Soochow University (1)

Countries

China (1)

Top investigators

Suning Chen, MD, PhD (1)